Inicio › Enfermedades autoinmunes › Carolina del Norte
Ensayos clínicos de Enfermedades autoinmunes en Carolina del Norte
20 estudios sobre Enfermedades autoinmunes buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1020, Chapel Hill
- Site Number - 1013, Durham
- Site Number - 1044, Raleigh
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
ReclutandoFase 2/3
Edades de 6 a 75 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06154252A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Duke University Medical Center, Durham
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06056297Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- On Site Clinical Solutions Llc, Charlotte
- Carolina Arthritis Associates, Wilmington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07621809Study of PTC844 in Participants With Active Rheumatoid Arthritis
- DJL Clinical Research PLLC, Charlotte
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07779616A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06722235A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Atrium Health Rheumatology-Southpark, Charlotte
- Duke University Medical Center, Durham
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07085104A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT06948318Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
- Site 113, Wilmington
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07885605A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- East Carolina University, Greenville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07059000Daratumumab in Primary Antiphospholipid Syndrome
- Duke University, Durham
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05671757Environmental Risk Factors for the Anti-synthetase Syndrome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 2 a 100 · Todos los sexos · Actualizado el 16 oct 2026 · NCT01276470RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Duke University, Durham
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06328777RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- UNC Chapel Hill, Chapel Hill
ReclutandoFase 1/2
Edades de 12 a 65 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06121297A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Durham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384Study of BHV-1300 in Graves' Disease
- Site-108, Greenville
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06980649A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Duke University, Durham
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT07115745A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital, Charlotte
- Duke University Medical Center, Durham
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Duke University Health System, Durham
ReclutandoFase 1
Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Duke University, Durham
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Todas las edades · Mujeres · Actualizado el 8 ene 2026 · NCT03276923De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.